Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation

Background: Gualou Xiebai Decoction (GLXB) is a classic prescription of Chinese medicine used for the treatment of cardiac problems. The present study was designed to explore the effect and mechanism of GLXB on ischemia/reperfusion (I/R) induced disorders in myocardial structure and function, focusi...

Full description

Bibliographic Details
Main Authors: Lu-Lu Yan, Wei-Yang Zhang, Xiao-Hong Wei, Li Yan, Chun-Shui Pan, Yang Yu, Jing-Yu Fan, Yu-Ying Liu, Hua Zhou, Jing-Yan Han, Xin-Sheng Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Physiology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphys.2018.00296/full
_version_ 1818031211995463680
author Lu-Lu Yan
Lu-Lu Yan
Wei-Yang Zhang
Xiao-Hong Wei
Xiao-Hong Wei
Li Yan
Chun-Shui Pan
Yang Yu
Jing-Yu Fan
Yu-Ying Liu
Yu-Ying Liu
Hua Zhou
Jing-Yan Han
Jing-Yan Han
Xin-Sheng Yao
Xin-Sheng Yao
author_facet Lu-Lu Yan
Lu-Lu Yan
Wei-Yang Zhang
Xiao-Hong Wei
Xiao-Hong Wei
Li Yan
Chun-Shui Pan
Yang Yu
Jing-Yu Fan
Yu-Ying Liu
Yu-Ying Liu
Hua Zhou
Jing-Yan Han
Jing-Yan Han
Xin-Sheng Yao
Xin-Sheng Yao
author_sort Lu-Lu Yan
collection DOAJ
description Background: Gualou Xiebai Decoction (GLXB) is a classic prescription of Chinese medicine used for the treatment of cardiac problems. The present study was designed to explore the effect and mechanism of GLXB on ischemia/reperfusion (I/R) induced disorders in myocardial structure and function, focusing on the regulation of energy metabolism and the RhoA/ROCK pathway.Methods: After hyperlipidemic rat model was established by oral administration of high fat diet, the rats were treated with GLXB for 6 weeks and subjected to 30 min occlusion of the left anterior descending coronary artery (LADCA) followed by 90 min reperfusion to elicit I/R challenge. Myocardial infarct size was assessed by Evans blue-TTC staining. Myocardial blood flow (MBF) and cardiac function were evaluated. Enzyme-linked immunosorbent assay was performed to examine the content of ATP, ADP, AMP, CK, CK-MB, LDH, cTnT, cTnI, and IL-6. Double staining of F-actin and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling was conducted to assess myocardial apoptosis. Expressions of ATP synthase subunit δ (ATP 5D), and RhoA and ROCK were determined by Western blotting.Results: Administration with GLXB at high dose for 6 weeks protected heart against I/R-induced MBF decrease, myocardial infarction and apoptosis, ameliorated I/R-caused impairment of cardiac function and myocardial structure, restored the decrease in the ratio of ADP/ATP and AMP/ATP, and the expression of ATP 5D with inhibiting the expression of RhoA and ROCK.Conclusions: Treatment with GLXB effectively protects myocardial structure and function from I/R challenge, possibly via regulating energy metabolism involving inactivation of RhoA/ROCK signaling pathway.
first_indexed 2024-12-10T05:47:53Z
format Article
id doaj.art-b36ab70799bc48948a7dc23b1405ac35
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-10T05:47:53Z
publishDate 2018-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-b36ab70799bc48948a7dc23b1405ac352022-12-22T02:00:06ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2018-04-01910.3389/fphys.2018.00296338992Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy ModulationLu-Lu Yan0Lu-Lu Yan1Wei-Yang Zhang2Xiao-Hong Wei3Xiao-Hong Wei4Li Yan5Chun-Shui Pan6Yang Yu7Jing-Yu Fan8Yu-Ying Liu9Yu-Ying Liu10Hua Zhou11Jing-Yan Han12Jing-Yan Han13Xin-Sheng Yao14Xin-Sheng Yao15State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, ChinaTasly Microcirculation Research Center, Peking University Health Science Center, Beijing, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, ChinaTasly Microcirculation Research Center, Peking University Health Science Center, Beijing, ChinaDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, ChinaTasly Microcirculation Research Center, Peking University Health Science Center, Beijing, ChinaTasly Microcirculation Research Center, Peking University Health Science Center, Beijing, ChinaInstitute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, Guangzhou, ChinaDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, ChinaTasly Microcirculation Research Center, Peking University Health Science Center, Beijing, ChinaDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, ChinaTasly Microcirculation Research Center, Peking University Health Science Center, Beijing, ChinaDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, ChinaInstitute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, Guangzhou, ChinaBackground: Gualou Xiebai Decoction (GLXB) is a classic prescription of Chinese medicine used for the treatment of cardiac problems. The present study was designed to explore the effect and mechanism of GLXB on ischemia/reperfusion (I/R) induced disorders in myocardial structure and function, focusing on the regulation of energy metabolism and the RhoA/ROCK pathway.Methods: After hyperlipidemic rat model was established by oral administration of high fat diet, the rats were treated with GLXB for 6 weeks and subjected to 30 min occlusion of the left anterior descending coronary artery (LADCA) followed by 90 min reperfusion to elicit I/R challenge. Myocardial infarct size was assessed by Evans blue-TTC staining. Myocardial blood flow (MBF) and cardiac function were evaluated. Enzyme-linked immunosorbent assay was performed to examine the content of ATP, ADP, AMP, CK, CK-MB, LDH, cTnT, cTnI, and IL-6. Double staining of F-actin and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling was conducted to assess myocardial apoptosis. Expressions of ATP synthase subunit δ (ATP 5D), and RhoA and ROCK were determined by Western blotting.Results: Administration with GLXB at high dose for 6 weeks protected heart against I/R-induced MBF decrease, myocardial infarction and apoptosis, ameliorated I/R-caused impairment of cardiac function and myocardial structure, restored the decrease in the ratio of ADP/ATP and AMP/ATP, and the expression of ATP 5D with inhibiting the expression of RhoA and ROCK.Conclusions: Treatment with GLXB effectively protects myocardial structure and function from I/R challenge, possibly via regulating energy metabolism involving inactivation of RhoA/ROCK signaling pathway.http://journal.frontiersin.org/article/10.3389/fphys.2018.00296/fullcardiac functionmyocardial structureATP synthase subunitapoptosisRho-associated protein kinaseRho GTPases
spellingShingle Lu-Lu Yan
Lu-Lu Yan
Wei-Yang Zhang
Xiao-Hong Wei
Xiao-Hong Wei
Li Yan
Chun-Shui Pan
Yang Yu
Jing-Yu Fan
Yu-Ying Liu
Yu-Ying Liu
Hua Zhou
Jing-Yan Han
Jing-Yan Han
Xin-Sheng Yao
Xin-Sheng Yao
Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation
Frontiers in Physiology
cardiac function
myocardial structure
ATP synthase subunit
apoptosis
Rho-associated protein kinase
Rho GTPases
title Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation
title_full Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation
title_fullStr Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation
title_full_unstemmed Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation
title_short Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation
title_sort gualou xiebai decoction a traditional chinese medicine prevents cardiac reperfusion injury of hyperlipidemia rat via energy modulation
topic cardiac function
myocardial structure
ATP synthase subunit
apoptosis
Rho-associated protein kinase
Rho GTPases
url http://journal.frontiersin.org/article/10.3389/fphys.2018.00296/full
work_keys_str_mv AT luluyan gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT luluyan gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT weiyangzhang gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT xiaohongwei gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT xiaohongwei gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT liyan gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT chunshuipan gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT yangyu gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT jingyufan gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT yuyingliu gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT yuyingliu gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT huazhou gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT jingyanhan gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT jingyanhan gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT xinshengyao gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation
AT xinshengyao gualouxiebaidecoctionatraditionalchinesemedicinepreventscardiacreperfusioninjuryofhyperlipidemiaratviaenergymodulation